 |
|
| Venture Capital Alphabetical (page 2 of 240) |
|
-AAC-
Offices: The Netherlands, London, England & Stockholm, Sweden
AAC Capital Partners is a leading Northern European mid-market buy-out firm
with a unique regional footprint. Made up of the former Dutch, Nordic and
UK buy-out teams of ABN AMRO Capital, they lead buy-outs within the €50
- 500 million deal range in the consumer, industrial and services sector.
AAC targets opportunities for majority stakes in profitable, cash-generative
companies headquartered in the Netherlands, Nordic region and the UK.
Offices: Cedar Rapids, Iowa
AAVIN is a private equity firm who invest in high-growth opportunities,
management buyouts and certain recapitalization transactions. They partner
with strong management teams seeking to build businesses through internal
growth or acquisitions. They invest primarily in late-stage and expansion-stage
financings.
Offices: New York, New York
Abbott Capital was founded in 1986 as an independent registered investment
adviser and has focused exclusively on private equity—venture capital, buyouts
and special situations—by making investments in professionally managed partnerships.
Abbott Capital offers a unique combination of performance, continuity among
senior professionals and alignment of interests that stems from its history
as an independent manager focused solely on private equity investments.
Offices: San Francisco, California
The Aberdare Ventures team are experienced venture investors and operators
of healthcare technology companies. Their investment focus is driven by
their years of experience growing biopharmaceutical product companies and
therapeutic medical device companies. They have plenty of experience leading
early-stage investments, but they are comfortable co-investing as well.
Aberdare is willing to participate in financings as small as $1 million,
but also has the capacity to invest $4-7 million in a company over time.-Abingworth-
Offices: Palo Alto, California; Boston, Massachusetts & London, England
Abingworth is a long-established venture capital firm specializing in unquoted
and life science biomedical companies. Abingworth is active on both sides
of the Atlantic and, in the past fifteen years, has backed more than 80
developing life science/medical businesses. The majority of these have gone
on to public offerings or have merged or been acquired by leading companies
in the industry. Abingworth has funds under management of over $700 million.
Offices: Chicago, Illinois
ABN AMRO Private Equity invests across a broad spectrum of the communications
industry. The combination of the migration to packet-based communications
networks and The Telecommunications Act of 1996 have forever changed the
landscape of the communications industry. ABN AMRO Private Equity believes
that increased competition, new technologies and decreased regulation will
all lead to continued explosive growth in communications sector.
Offices: Boston, Massachusetts
ABRY Partners is one of the most experienced and successful media-focused
private equity investment firms in North America. Since 1989, ABRY has completed
over $7.0 billion of leveraged transactions and other private equity and
mezzanine investments, representing investments in more than 450 media properties.
ABRY typically invests $20 million to $100 million of equity or $10 million
to $50 million of mezzanine capital in a company, and currently has approximately
$1.7 billion of total capital under management.
Offices: Baltimore, Maryland; Boston, Massachusetts & San Francisco,
California
ABS has $1.5 billion under management and ten investing partners. Over the
past twelve years, ABS Capital has invested in over 60 portfolio companies.
The firm's investment strategy focuses on companies in the health care,
technology, business services and media & communications sectors.
Print
(page 3)
Resources
to
top